Niclosamide formulations for treating disease
US11324708B1 · kind B1 · utility
2Cited by
17References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 25, 2021 |
| Grant date | May 10, 2022 |
| Priority date | — |
| Expiry date | May 25, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a method of treating a viral infection caused by or associated with SARS-CoV-2 in a subject, the method comprising administering to the subject by inhalation intraorally and/or intranasally a therapeutically effective amount of a formulation comprising niclosamide, or a pharmaceutically acceptable salt thereof, and a cyclodextrin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.